Dr. Amin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19, Brdhurst Road
Hawthorne, NY 10532Phone+1 914-493-7585
Education & Training
Westchester Medical CenterFellowship, Pediatric Pulmonology, 1991 - 1994- Westchester Medical CenterResidency, Pediatrics, 1985 - 1989
Baroda Medical CollegeClass of 1979
Certifications & Licensure
NY State Medical License 1988 - 2026- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2009-2019
Publications & Presentations
PubMed
- 64 citationsSafety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.Klaus F. Rabe, Bartolome R. Celli, Michael E. Wechsler, Raolat M Abdulai, Xiaodong Luo
The Lancet. Respiratory Medicine. 2021-07-21 - 659 citationsLong-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-...Andrew Blauvelt, Marjolein S. de Bruin-Weller, Melinda Gooderham, Jennifer Clay Cather, Jamie Weisman
Lancet. 2017-06-10 - 602 citationsEfficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multi...Claus Bachert, Joseph K. Han, Martin Desrosiers, Peter Hellings, Nikhil Amin
Lancet. 2019-11-02
Journal Articles
- Dupilumab Reduces Severe Exacerbation Rate and Improves Lung Function in Adolescent Patients with Uncontrolled, Moderate-to-Severe Asthma: From the Liberty Asthma Ques...Sally Wenzel, Neil Graham, Jaman Maroni, Nikhil Amin, Maspero J, Fitzgerald M, Pavord I, et al.
Press Mentions
- Glenmark Gets USFDA Nod to Begin Trials for Potential Cancer DrugMarch 16th, 2023
- New Clinical Trial for Advanced Solid Tumors and Hodgkin’s LymphomaApril 11th, 2022
Professional Memberships
- Member
- Member
- European Respiratory society eMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
